Cannabis Law Report
OCTOBER 2, 2021
We are pioneering a new kind of pharmaceutical company that prioritizes public benefit and is committed to sustainability, accountability, and transparency. Team leadership: mentor European study teams in overall regulatory strategy and compliance to enable future patient access expeditiously. Pet Insurance. FSA/Dep Care.
Cannabis Law Report
NOVEMBER 19, 2021
We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Contract control : review and interpret corporate contracts, non-disclosure agreements, data processing agreements, fiscal sponsorship agreements, and other legal compliance documents.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
NOVEMBER 19, 2021
We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Team leadership : mentor European study teams in overall regulatory strategy and compliance to enable future patient access expeditiously. Pet Insurance. FSA/Dep Care.
Cannabis Law Report
JULY 13, 2021
The company has several other products and trademarked brands in late stages of development, including cosmetics, feminine care, pet health and wellness, and dental and oral care products. All products are manufactured in an FDA-registered facility and follow Current Good Manufacturing Practice (CGMP) guidelines.
Cannabis Law Report
FEBRUARY 27, 2020
Businesses in a wide range of industries – wellness, food and drink, energy, tobacco, pharmaceutical, even cosmetics and pet food – are seeking to understand how cannabis products will affect their markets.
Cannabis Law Report
JULY 24, 2019
Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. Full report at. Full Letter. Source: [link]. 321(g)(1)(B).
Cannabis Law Report
SEPTEMBER 12, 2022
All but two states have followed suit in legalizing hemp, and most have submitted hemp regulation plans to the USDA as required to demonstrate how the state intends to control and track hemp in compliance with regulations promulgated by the USDA for hemp production last year. .
Expert insights. Personalized for you.
52 
Let's personalize your content